The Expression of Multiple Proteins as Prognostic Factors in Colorectal Cancer: Cathepsin D, p53, COX-2, Epidermal Growth Factor Receptor, C-erbB-2, and Ki-67
Authors:
Open Access
- 15 January 2014
- journal article
- Published by The Editorial Office of Gut and Liver in Gut and Liver
- Vol. 8 (1) , 13-23
Abstract
A single gene mutation alone cannot explain the poor prognosis of colorectal cancer. This study aimed to establish a correlation between the expression of six proteins and the prognosis of colorectal cancer patients. Tissue samples were collected from 266 patients who underwent surgery for colorectal cancer at our institution from January 2006 to December 2007. The expression of six proteins were determined using immunohistochemical staining of specimens. Cathepsin D, p53, COX-2, epidermal growth factor receptor, c-erbB-2, and Ki-67 expression were detected in 38.7%, 60.9%, 37.6%, 35.7%, 30.1%, and 74.4% of the samples, respectively. The expression of cathepsin D was significantly correlated with reduced cancer-free survival (p=0.036) and colorectal cancer-specific survival (p=0.003), but the other expression levels were not. In a multivariate analysis, cathepsin D expression was found to be an independent prognostic factor for poorer colorectal cancer-specific survival (hazard ratio, 8.55; 95% confidence interval, 1.07 to 68.49). Furthermore, patients with tumors expressing four or more of the proteins had a significantly decreased cancer-free survival rate (p=0.006) and colorectal cancer-specific survival rate (p=0.002). Patients with cathepsin D positivity had a poorer outcome than patients who were cathepsin D-negative. Thus, cathepsin D may provide an indicator for appropriate intensive follow-up and adjuvant chemotherapy.Keywords
This publication has 39 references indexed in Scilit:
- Cathepsin D Expression in Colorectal Cancer: From Proteomic Discovery through Validation Using Western Blotting, Immunohistochemistry, and Tissue MicroarraysInternational Journal of Proteomics, 2012
- Prognostic and Predictive Biomarkers in Resected Colon Cancer: Current Status and Future Perspectives for Integrating Genomics into Biomarker DiscoveryThe Oncologist, 2010
- Is overexpression of HER-2 a predictor of prognosis in colorectal cancer?BMC Cancer, 2009
- Cyclooxygenase-2 Expression in Human Colorectal Cancer Is Unrelated to Overall Patient SurvivalClinical Cancer Research, 2005
- Molecular Staging for Survival Prediction of Colorectal Cancer PatientsJournal of Clinical Oncology, 2005
- Gene expression profiling of colon cancer by DNA microarrays and correlation with histoclinical parametersOncogene, 2004
- A Gene-Expression Signature as a Predictor of Survival in Breast CancerNew England Journal of Medicine, 2002
- Gene expression profiling predicts clinical outcome of breast cancerNature, 2002
- The Hallmarks of CancerCell, 2000
- Immunohistochemical Evaluation of Cathepsin D Expression in Colorectal CancerCancer Investigation, 1997